A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis
Clinical trial NCT02977533 · COMPLETED
Trial details
- NCT number
- NCT02977533
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-05-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.